Objectives: Gram-positive microorganisms have been the predominant pathogens in central venous catheterrelated bloodstream infections (CRBSIs). Recent guidelines recommend empirical therapy according to this and restrict coverage for Gram-negatives to specific circumstances. This study aimed to analyse the epidemiological changes in CRBSIs over the 1991-2008 period and to analyse predictors of Gram-negative CRBSIs.
Introduction
The common use of central venous catheters (CVCs) among inpatients is associated with potential complications. In particular, CVC-related bloodstream infections (CRBSIs) result in increased morbidity and mortality as well as extra costs. These infections are estimated to have an attributable mortality ranging from 12% to 25% in the USA, with an added cost ranging from US$3000 to US$56 167 per episode. 1 The management of CRBSIs includes selection of the correct empirical therapy. In this setting, Gram-positive coverage is routinely recommended and, according to current guidelines, additional empirical coverage for Gram-negative pathogens should be considered for critically ill or neutropenic patients, and for those with a femoral catheter or a known focus of Gramnegative infection. 2 In addition, other authors have identified post-operative status or diabetes 3 as predictors for CRBSIs due to Gram-negative strains. In spite of these data, these risk factors have not been clearly validated and, therefore, there are few data available to decide which patients with a suspected CRBSI should receive Gram-negative antibiotic coverage. Furthermore, the increasing rate of Gram-negative pathogens in healthcare-associated bloodstream infections 4 and the complications associated with these infections 5 deserve increasing attention, especially in common infections such as CRBSIs.
The aim of our study was to analyse the epidemiological trends in CRBSIs over the 1991-2008 period in a university hospital among inpatients with central venous catheters placed during admission, and to evaluate the frequency and predictors of Gram-negative CRBSIs in this setting.
Patients and methods

Study design
This study included all monomicrobial episodes of definite CRBSIs diagnosed from January 1991 to December 2008 among inpatients. Only non-tunnelled venous catheters inserted during admission were included and, therefore, episodes related to tunnelled, arterial catheters or catheters inserted prior to admission were excluded. The study was performed at the Hospital Clinic in Barcelona (Spain), a 700 bed university centre that serves an urban population of 500000 people. During the study period, the decision whether to insert or remove a catheter as well as to use a specific access was made by the patient's physician. The catheters used were non-antimicrobial-coated and were inserted by physicians with standard sterile barrier precautions.
The patients were identified from the bacteraemia registry maintained by the Department of Infectious Diseases. The following data at the time of bloodstream infection diagnosis were obtained for all patients and prospectively recorded in the registry: age; sex; pre-existing co-morbidities; administration of immunosuppressive therapy; postoperative status; admission date; catheter insertion date; and antibiotics used in the month prior to bacteraemia. The presence of the following factors when the blood cultures were taken was also documented: exitsite infection; need for mechanical ventilation; presentation with septic shock (early shock); presentation with fever; a CVC; or an indwelling urinary catheter. Patients were followed up from the time of bacteraemia diagnosis to assess 30 day overall mortality. The Ethics Committee of the Clínic Hospital of Barcelona approved this study and no informed consent was sought, since this was an observational study and clinical care was not influenced.
Definitions of terms
CRBSI was considered definite when there was at least one positive peripheral blood culture and one of the following findings: (i) a positive semi-quantitative or quantitative catheter-tip culture that grew the microorganism found in the peripheral blood (this criterion was applied during the entire study); or (ii) a positive paired central and peripheral blood culture that grew the same microorganism-the former blood culture was positive ≥2 h earlier (this criterion was applied after 2000). 6 Co-morbidity was defined as a disease or therapy that could predispose patients to infection, alter defence mechanisms or cause functional impairment, such as the following: diabetes; liver cirrhosis; renal failure; active neoplastic disease; solid organ or bone marrow transplantation; neutropenia; severe chronic obstructive pulmonary disease; severe cardiac disease with symptomatic heart failure; HIV infection; and administration of immunosuppressive drugs (.20 mg of corticosteroids/day on a regular basis or antineoplastic chemotherapy). Prognosis of the underlying disease was classified, according to McCabe and Jackson modified criteria, 7 as rapidly fatal (when death was expected within 3 months), ultimately fatal (when death was expected within a period of .3 months but ,5 years) and non-fatal (when life expectancy was .5 years). Shock was defined as sepsis associated with evidence of organ hypoperfusion and a systolic blood pressure of ,90 mm Hg or of .30 mm Hg less than the baseline that did not respond to fluid treatment and required vasoactive drug therapy. 8 Exit-site infection was defined by microbiological criteria (microorganism isolated from purulent discharge from the catheter exit site) or clinical criteria (erythema, induration, pus emerging from the exit site and/or tenderness within 2 cm of the catheter exit site). Gram-negative CRBSI incidence was defined as the number of episodes/1000 patient-days.
Microbiological methods
Between 1991 and 1997, blood samples were processed by the BACTEC NR-730 system (Becton-Dickinson Microbiology System) and maintained routinely for 7 days. Since 1998 we have used the BACTEC 9240 system (Becton-Dickinson Microbiology System) with an incubation period of 5 days. Isolates were identified according to standard techniques. Antibiotic susceptibility was determined by the disc diffusion method, according to the recommendations of the CLSI (formerly NCCLS) guidelines. 9 Intermediate susceptibility to each antibiotic was considered as resistance.
Statistical analysis
Categorical variables were compared by the x 2 test or Fisher's exact test (if expected cell counts were ,5) and continuous variables were compared by Student's t-test. A x 2 trend test was used to evaluate the differences observed during the study period. A multivariable regression model was used to identify the independent factors predictive of developing Gram-negative CRBSIs. Clinically relevant variables that may influence the development of Gram-negative CRBSIs and with a P,0.20 in univariate analysis were subjected to further selection by using a backward stepwise logistic procedure, and the model obtained was confirmed by means of a non-stepwise analysis in order to check the accuracy of the model. The presence of collinearity was tested using the variance inflation factor (VIF) and tolerance. 10 The calibration of the model was assessed by means of the Hosmer -Lemeshow goodness-of-fit test. A two-tailed P value ,0.05 was regarded as significant. Statistical analyses were performed using the Statistical Package for the Social Sciences version 15.0 (Chicago, IL, USA).
Results
During the 18 year study period, 19434 positive blood cultures were obtained and 1129 episodes (5.8%) of monomicrobial CRBSIs were found among 1078 patients. Of these 1129 episodes, 774 (68.6%) were due to Gram-positive bacteria, 284 (25.2%) to Gram-negative bacteria and 70 (6.2%) to Candida spp. The microorganisms responsible for these episodes are shown in Table 1 . There was a significant increase over time in the number of Gram-negative CRBSIs among the total CRBSIs, rising from 3 episodes (4.69%) in 1991 -92 to 70 (40.23%) in 2007-08 (P,0.001, Table 2 ), with a parallel decrease in the percentage of Gram-positive CRBSIs (from 82.8% to 52.9%) and no significant trend changes in the percentage of Candida spp. isolates ( Figure 1 ). The overall incidence of CRBSIs increased from 0.10 episodes/1000 patient-days in 1991-92 to 0.31 in 2007 -08 (Figure 2) , with a greater increase in CRBSIs due to Gramnegative strains (0.0047 to 0.13 episodes/1000 patient-days) than in those due to Gram-positive strains (0.083 to 0.17 episodes/1000 patient-days). Accordingly, the number of CRBSI episodes among total bacteraemia episodes significantly increased (P,0.001, Table 2 ) from 1991 -92 (64 episodes, 3.79%) to 2007-08 (174 episodes, 7.03%). No particular Gram-negative microorganism contributed disproportionately to the overall increase in Gram-negative CRBSIs (Figure 3) .
Among the 1012 patients with 1058 episodes of monomicrobial CRBSIs due to Gram-negative or Gram-positive microorganisms, we further analysed predictive factors for developing a Gram-negative CRBSI. The clinical and demographic characteristics of these patients are shown in Table 3 , and the antibiotics received during the month prior to bacteraemia are listed in Table 4 . Patients with Gram-negative bacteraemia had their catheters inserted for a longer time before onset of bacteraemia than those with Gram-positive bacteraemia (P ¼ 0.009) and had been admitted for a longer period (P ¼ 0.039). Other variables significantly associated with Gram-negatives in the univariate analysis were female sex, presentation with septic shock, solid organ transplantation, HIV infection, McCabe prognosis, postoperative status, presence of bladder catheter, reception of immunosuppressive drugs, neutrophil count ,500/mL (Table 3) , and previous antibiotic treatment, particularly with penicillins (Table 4) . Variables associated with a lower risk of Gramnegatives were the presence of cirrhosis or diabetes (Table 3) and previous treatment with fluoroquinolones (Table 4) .
After regression logistic analysis, variables independently associated with the risk of having a Gram-negative pathogen as a cause of CRBSI were the following: solid organ transplantation [odds ratio (OR) 1.98, 95% confidence interval (CI) 1.18 -3.33]; prior use of penicillins (OR 2.17, 95% CI 1.54-3.06); and hospital stay longer than 11 days before the onset of 
Discussion
In our study, we have found a significant increase in the proportion of CRBSI episodes caused by Gram-negative bacteria over a period of 18 years. Of note, the relative contribution of these pathogens to CRBSIs reached 40% for the 2007 -08 period. Although our data come from a single centre and therefore the epidemiology of CRBSIs may be different in other settings, this shift in the aetiology of CRBSIs parallels other recent reports that have also shown an increase in the rate of Gramnegative bacteraemia in several settings, including healthcare-associated bloodstream infections. 4, 11, 12 No specific pathogens contributed to this rise in Gram-negative strains, and the leading strains were Pseudomonas aeruginosa and Enterobacteriaceae (particularly Klebsiella spp., Escherichia coli, Serratia spp. and Enterobacter spp.), in agreement with other reports. 3, 4, 13, 14 This rise in the incidence of Gram-negatives was, at least in part, due to an increase in strains resistant to 1 9 9 1 -9 2 1 9 9 3 -9 4 1 9 9 5 -9 6 1 9 9 7 -9 8 
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cephalosporins, carbapenems and ciprofloxacin that has been also reported by other authors. 12 Considering the absence of described outbreaks and that there were no important changes in the practice of CVC use (such as coated catheter usage) during this period in our institution, possible explanations for the rise in Gram-negative episodes are the increasing complexity of our patients along this period of time (i.e. the number of patients receiving a solid organ transplant), the need for longer stays in certain patients or the wide use of antibiotics that may select resistant microorganisms. 15, 16 This increasing complexity of patient care, which determines more catheters placed for longer periods, is also able to explain the rise observed in the incidence of CRBSIs/1000 patient-days. Further, we have to consider that the use of differential time to positivity as a method for diagnosing CRBSIs may have also increased the number of episodes after 2000. We do not believe, however, Epidemiology of catheter-related bacteraemia that this fact will have affected the study to a great extent, since all catheter tips were routinely sent to culture when CRBSIs were suspected and all positive cultures were further followed by an infectious diseases specialist. In any case, this finding reinforces the actual importance of CRBSIs as a leading cause of nosocomial bacteraemia. 1 Unfortunately, information for calculating CRBSI incidence/1000 central line-days was not available and we acknowledge that this is a limitation for this part of our study.
The main objective of our work, however, was to evaluate the aetiology of CRBSIs and the clinical consequences in the management of these infections. In this regard, this is the first report clearly showing an increased incidence of Gram-negatives in CRBSIs and suggesting that empirical therapy with Gramnegative coverage should be routinely considered in these infections. Patients admitted .11 days prior to bacteraemia, which may be associated with higher risk of colonization with Gramnegative strains, 17, 18 those with solid organ transplantation 19, 20 and those who previously received penicillins had a higher risk of Gram-negative CRBSIs. On the other hand, diabetes and cirrhosis were associated with a lower risk of Gram-negative catheter-related bacteraemia, which could be explained by a higher Staphylococcus aureus nasal carriage rate among diabetic and cirrhotic patients 21, 22 as well as by prophylactic norfloxacin administration to cirrhotic patients. 23, 24 Indeed, the use of quinolones in the 30 days prior to bacteraemia was associated with a lower risk of developing Gram-negative CRBSIs in our study. In line with these findings, a study analysing patients with febrile neutropenia showed that those who had recently received b-lactams had a higher probability of suffering from a Gramnegative bacterial infection, whereas those who had received quinolones had a lower risk. 25 In any case, although our multivariable analysis has identified several subgroups of patients with a lower risk of Gram-negative CRBSIs, we must be aware that patients with these predictors still have a considerably high prevalence of Gram-negative infection. As outlined above, Gram-negative strains were responsible for 20% of CRBSI episodes in patients with cirrhosis, diabetes or with a prior history of receiving quinolones. Therefore, even in these groups with a significantly lower risk of Gram-negative CRBSIs, the prevalence of Gram-negatives would be high enough to empirically recommend coverage against these strains in our setting. We are aware, however, that our data come from an observational study in a single centre and that, to date, no other studies have reported such a clear increase in Gram-negative strains as a cause of CRBSIs. Therefore, our data may be heavily influenced by local factors, such as patient population or variability in catheter care or antibiotic use.
In conclusion, Gram-negative strains are an increasing cause of CRBSIs, reaching 40% in our hospital during 2007 -08. If these data are confirmed in other series, this could imply a revision of the management of CRBSIs, with the recommendation of a broad-spectrum empirical therapy.
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